A May 2024 cohort study reveals prenatal PFAS exposure reduces maternal beta cell function by 15-20%, increasing diabetes risk. EU proposals and NIH funding highlight urgent public health responses. R...
Emerging research shows prenatal PFAS exposure significantly impacts maternal metabolic health, increasing risks of gestational diabetes and long-term beta cell dysfunction. Groundbreaking studies dem...
New research reveals prenatal PFAS exposure disrupts maternal beta cell function, increasing gestational diabetes risk by up to 40%, with actionable prevention strategies. Groundbreaking study shows &...
Latent autoimmune diabetes in adults (LADA) is often misdiagnosed as type 2 diabetes. This article explores its clinical characteristics, diagnostic challenges, and optimal management strategies. LADA...